These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21084937)

  • 1. How appropriate are the american college of radiology appropriateness criteria for ovarian cancer screening.
    Dubinsky TJ
    Ultrasound Q; 2010 Dec; 26(4):225-6. PubMed ID: 21084937
    [No Abstract]   [Full Text] [Related]  

  • 2. Ovarian cancer screening. American College of Radiology. ACR Appropriateness Criteria.
    Böhm-Vélez M; Mendelson E; Bree R; Finberg H; Fishman EK; Hricak H; Laing F; Sartoris D; Thurmond A; Goldstein S
    Radiology; 2000 Jun; 215 Suppl():861-71. PubMed ID: 11037511
    [No Abstract]   [Full Text] [Related]  

  • 3. ACR appropriateness criteria© ovarian cancer screening.
    Brown DL; Andreotti RF; Lee SI; Dejesus Allison SO; Bennett GL; Dubinsky T; Glanc P; Horrow MM; Lev-Toaff AS; Horowitz NS; Podrasky AE; Scoutt LM; Zelop CM
    Ultrasound Q; 2010 Dec; 26(4):219-23. PubMed ID: 21084936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mass-screening for ovarian cancer].
    Sato S; Higuchi T; Yokoyama Y; Sakamoto T
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():601-4. PubMed ID: 15535316
    [No Abstract]   [Full Text] [Related]  

  • 5. Personalizing ovarian cancer screening.
    Goozner M
    J Natl Cancer Inst; 2010 Aug; 102(15):1112-3. PubMed ID: 20668268
    [No Abstract]   [Full Text] [Related]  

  • 6. A step forward for two-step screening for ovarian cancer.
    Hensley ML
    J Clin Oncol; 2010 May; 28(13):2128-30. PubMed ID: 20368556
    [No Abstract]   [Full Text] [Related]  

  • 7. Circulating tumour markers in ovarian tumours.
    von Schlippe M; Rustin GJ
    Forum (Genova); 2000; 10(4):383-92. PubMed ID: 11535987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CA-125: a biomarker put to the test.
    Schmidt C
    J Natl Cancer Inst; 2011 Sep; 103(17):1290-1. PubMed ID: 21852262
    [No Abstract]   [Full Text] [Related]  

  • 9. [Screening for ovarian cancers: critical analysis].
    Pennehouat G; Gugliemina JN; Naouri M; Créquat J; Bouret JM; Thébault Y; Madelenat P
    Contracept Fertil Sex; 1993 Mar; 21(3):223-30. PubMed ID: 7951617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for ovarian cancer.
    Emery J; Yaphe J; Priest P; Whiteman D
    Lancet; 1999 Aug; 354(9177):509; author reply 510. PubMed ID: 10465193
    [No Abstract]   [Full Text] [Related]  

  • 11. [The characteristics of CA125/MUC16].
    Hiraike O; Yano T; Taketani Y
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():681-4. PubMed ID: 20960850
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening for ovarian cancer.
    Manassiev N
    Lancet; 1999 Aug; 354(9177):509; author reply 510. PubMed ID: 10465192
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening for ovarian cancer.
    Chappuis PO; Narod SA; Foulkes WD
    Lancet; 1999 Aug; 354(9177):509-10. PubMed ID: 10465194
    [No Abstract]   [Full Text] [Related]  

  • 14. Progress report on ovarian cancer screening. Scientists are making headway in detecting ovarian cancer at an earlier stage.
    Harv Womens Health Watch; 2010 Apr; 17(8):1-3. PubMed ID: 20506601
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic, biochemical, and multimodal approaches to screening for ovarian cancer.
    Jacobs I
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S22-7. PubMed ID: 7835805
    [No Abstract]   [Full Text] [Related]  

  • 16. [Serum tumor markers CA125 and HE4 in ovarian cancer patients].
    Sergeeva NS; Marshutina NV; Alentov II; Korneeva IA; Novikova EG
    Vopr Onkol; 2013; 59(2):12-21. PubMed ID: 23814844
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical applications of ovarian cancer biomarkers].
    Kataoka F; Aoki D
    Nihon Rinsho; 2012 Jun; 70 Suppl 4():543-8. PubMed ID: 23156306
    [No Abstract]   [Full Text] [Related]  

  • 18. [Screening for ovarian cancers: what is the role for marker levels?].
    Dargent D
    Gynecol Obstet Fertil; 2000 Nov; 28(11):855-9. PubMed ID: 11127045
    [No Abstract]   [Full Text] [Related]  

  • 19. The value of cancer antigen 125 (CA 125) during treatment and follow-up of patients with ovarian cancer.
    de Bruijn HW; van der Zee AG; Aalders JG
    Curr Opin Obstet Gynecol; 1997 Feb; 9(1):8-13. PubMed ID: 9090475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Listen for the "whispering disease". Learn the subtle signs and symptoms of ovarian cancer.
    Martin VR
    Nurs Manage; 2000 Apr; 31(4):30-1. PubMed ID: 15127636
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.